4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-21-059698
CHIEF FINANCIAL OFFICER sold 1,251 shares at $14.21 ($17,783)
- CHIEF FINANCIAL OFFICER acquired 7,918 shares (option exercise)
- CHIEF FINANCIAL OFFICER gave up 1,961 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Millar Kerri-Ann · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-23 | Exercise or conversion : show line 1 in the form | +6,667 | 12,433 | D | ||
| 2021-08-23 | Shares withheld for taxes : show line 2 in the form | −1,961 | 10,472 | D | ||
| 2021-10-01 | Exercise or conversion : show line 3 in the form | +1,251 | $7.50 | $9,383 | 11,723 | D |
| 2021-10-01 | Sale : show line 4 in the form | −1,251 | $14.21 | $17,783 | 10,472 | D |
| Open-market sales · 1,251 sh · avg $14.21 · $17,783 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-23 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −6,667 | 6,667 | D |
| 2021-10-01 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −1,251 | 53,749 | D |
Loading xslF345X03/doc4.xml…